KR870004977A - 2,2'-바이-1h-이미다졸 및 그의 제조방법 - Google Patents

2,2'-바이-1h-이미다졸 및 그의 제조방법

Info

Publication number
KR870004977A
KR870004977A KR1019860009901A KR860009901A KR870004977A KR 870004977 A KR870004977 A KR 870004977A KR 1019860009901 A KR1019860009901 A KR 1019860009901A KR 860009901 A KR860009901 A KR 860009901A KR 870004977 A KR870004977 A KR 870004977A
Authority
KR
South Korea
Prior art keywords
imidazole
preparation
Prior art date
Application number
KR1019860009901A
Other languages
English (en)
Other versions
KR900000671B1 (ko
Inventor
피.마테우즈 도날드
알.맥카티 제임스
피.휘텐 제프레이
Original Assignee
메렐 다우 파마슈티컬즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메렐 다우 파마슈티컬즈 인코포레이티드 filed Critical 메렐 다우 파마슈티컬즈 인코포레이티드
Publication of KR870004977A publication Critical patent/KR870004977A/ko
Application granted granted Critical
Publication of KR900000671B1 publication Critical patent/KR900000671B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019860009901A 1985-11-25 1986-11-24 2,2'-바이-1h-이미다졸 및 그의 제조방법 KR900000671B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80145885A 1985-11-25 1985-11-25
US801,458 1985-11-25

Publications (2)

Publication Number Publication Date
KR870004977A true KR870004977A (ko) 1987-06-02
KR900000671B1 KR900000671B1 (ko) 1990-02-02

Family

ID=25181154

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860009901A KR900000671B1 (ko) 1985-11-25 1986-11-24 2,2'-바이-1h-이미다졸 및 그의 제조방법

Country Status (19)

Country Link
EP (1) EP0229922B1 (ko)
JP (1) JPS62135461A (ko)
KR (1) KR900000671B1 (ko)
CN (1) CN86108027A (ko)
AT (1) ATE74912T1 (ko)
AU (1) AU585409B2 (ko)
CA (1) CA1286301C (ko)
DE (1) DE3684900D1 (ko)
DK (1) DK562686A (ko)
ES (1) ES2036520T3 (ko)
FI (1) FI864751A (ko)
GR (1) GR3004386T3 (ko)
HU (1) HU205087B (ko)
IL (1) IL80733A0 (ko)
NO (1) NO167801C (ko)
NZ (1) NZ218354A (ko)
PH (1) PH22526A (ko)
PT (1) PT83799B (ko)
ZA (1) ZA868809B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839375A (en) * 1987-07-28 1989-06-13 Merrell Dow Pharmaceuticals Inc. (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents
US7322704B2 (en) 2004-07-30 2008-01-29 Novalux, Inc. Frequency stabilized vertical extended cavity surface emitting lasers
JP4935090B2 (ja) * 2006-01-31 2012-05-23 ソニー株式会社 半導体発光装置
CN101676293B (zh) * 2008-09-18 2012-11-21 宁波大学 一种联咪唑有机膦化合物及其制备方法
CN102304089A (zh) * 2011-07-01 2012-01-04 中国科学院过程工程研究所 一种4,4′,5,5′-四硝基-2,2′-联咪唑的合成方法

Also Published As

Publication number Publication date
PT83799B (pt) 1988-08-17
HUT42075A (en) 1987-06-29
EP0229922A3 (en) 1988-03-30
NO167801B (no) 1991-09-02
IL80733A0 (en) 1987-02-27
AU585409B2 (en) 1989-06-15
FI864751A (fi) 1987-05-26
KR900000671B1 (ko) 1990-02-02
NO864695D0 (no) 1986-11-24
NO167801C (no) 1991-12-11
EP0229922A2 (en) 1987-07-29
ZA868809B (en) 1987-07-29
DE3684900D1 (de) 1992-05-21
ATE74912T1 (de) 1992-05-15
CA1286301C (en) 1991-07-16
HU205087B (en) 1992-03-30
EP0229922B1 (en) 1992-04-15
DK562686D0 (da) 1986-11-24
AU6556586A (en) 1987-05-28
DK562686A (da) 1987-05-26
JPS62135461A (ja) 1987-06-18
FI864751A0 (fi) 1986-11-21
NZ218354A (en) 1989-09-27
GR3004386T3 (ko) 1993-03-31
PT83799A (en) 1986-12-01
PH22526A (en) 1988-10-17
CN86108027A (zh) 1987-10-07
ES2036520T3 (es) 1993-06-01

Similar Documents

Publication Publication Date Title
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
DK165248C (da) 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
ATE58729T1 (de) Antianaphylaktische und antibronchospastische n- benzhydrylcycloalkylalkananilide.
TR22532A (tr) Piridazinon tuerevleri,bunlarin hazirlanmasi ve ensektisid,akarisid nematisid fungisid bilesikleri
TR25164A (tr) INTEKTISID ÖZELLIKTE N'-SüBSTITüENTLI-N,N-DIACIL- HIDRAZINLER
KR860005810A (ko) 4h-1-벤조피란-4-온 및 그 제조방법
DK416885D0 (da) Substitueret 1,4-dihydropyridincarbonyl-piperidinoforbindelser samtderes fremstilling og anvendelse
IT8521002A0 (it) 4' -desclororebeccamicina eprocedimento per la sua preparazione.
KR860004915A (ko) 아미노아실라브단 및 이의 제조방법
GB2183638B (en) Polyfluoroalkylisoxazolylamines, their preparation and use
DE3680771D1 (de) Isoxazolopyridophenoxazin- und isothiazolopyridophenoxazinderivate.
KR870004977A (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
DE3680775D1 (de) Isoxazolopyridobenzoxazin- und isothiazolopyridobenzoxazinderivate.
FI860525A0 (fi) Ny jordbrukskemikalie med namnet 'substance no.51262'.
DK212786A (da) 1,3-dioxanethere
DK388986D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
IT1213496B (it) Trimetilsililcarbammati e procedimento per la loro preparazione
DK1987D0 (da) Maltningsfremgangsmaade maltningsfremgangsmaade
IT1190646B (it) 2,4-dicloro-5-nitro-tiazolo
KR880700810A (ko) 2'-데옥시-5-트리플루오로메틸우리딘 유도체 및 그의 제조방법
ATA111785A (de) Bumerang
IT8565304V0 (it) Riga-compasso e squadra-compasso, nonche'quadro-prospettico
MA20618A1 (fr) Variete clementinier precoce "ripetri"
BR8502633A (pt) Metodo de preparacao de 2,3,5,6-tetracloropiridina
BG40556A1 (en) N- 4- bromphenyl- n'- arylthiocarbamides, method for preparation and use

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19921228

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee